Notifications
Clear all

Blocking a pathway unleashes the anti-cancer immune response


Daniel
(@daniel)
Admin
Joined: 6 years ago
Posts: 1046
Topic starter  

https://www.sciencedaily.com/releases/2021/02/210224120316.htm

Blocking the SREBP pathway unleashed a potent antitumor response in mice with melanoma treated with immunotherapy called anti-PD-1. 

SREBP inhibitors have been discussed here an includes Metformin https://www.cancertreatmentsresearch.com/?s=SREBP

This could explain why Metformin has been found to help with effectiveness of anti-PD-1 immunotherapy.


Quote
Share: